Biocon Company Profile

10,557 views
10,117 views

Published on

Breif PPt on Biocon\'s Company Profile

0 Comments
10 Likes
Statistics
Notes
  • Be the first to comment

No Downloads
Views
Total views
10,557
On SlideShare
0
From Embeds
0
Number of Embeds
5
Actions
Shares
0
Downloads
0
Comments
0
Likes
10
Embeds 0
No embeds

No notes for slide

Biocon Company Profile

  1. 2. Er. Aakash PRESENTS
  2. 3. BIOCON REDEFINING BIOLOGICAL EQUATIONS
  3. 4. Dr. KIRAN MAZUMDAR SHAW <ul><li>Dr. Kiran Mazumdar Shaw was born on 23 March, 1953 in Bangalore. </li></ul><ul><li>BSc in Zoology from Bangalore university in 1973. </li></ul><ul><li>Masters in brewing from University of Ballart, Australia in 1974. </li></ul><ul><li>Started working in Carlton & United Beverages in 1974 as a trainee. </li></ul><ul><li>She joined Biocon Biochemicals Limited in Ireland in 1978, as Trainee Manager . </li></ul>
  4. 5. BIRTH OF BIOCON <ul><li>She founded Biocon India with a capital of Rs. 10,000/- in 1978. </li></ul><ul><li>Started producing an digestive enzyme from papaya. </li></ul><ul><li>All the banks rejected their loan applications. </li></ul><ul><li>Company grew slowly </li></ul><ul><li>India’s largest biopharmaceutical company </li></ul><ul><li>India’s richest women- Rs. 2,100 crore. </li></ul>
  5. 6. Achievements by the MD <ul><li>Wharton Infosys Business Transformation Award (2006) </li></ul><ul><li>Padma Bhushan (2005). </li></ul><ul><li>The Economic Times Business Woman of the Year Award (2004) </li></ul><ul><li>Whirlpool GR8 Women award for Science and Technology (2004) </li></ul><ul><li>Ernst & Young Entrepreneur of the Year Award in Healthcare & Life Sciences Category (2002) </li></ul><ul><li>Padma Shri (1989) </li></ul><ul><li>Rotary award for the Best Model Employer (1983) </li></ul><ul><li>Gold for Best Woman Entrepreneur , Institute of Marketing Management (1982) </li></ul>
  6. 7. Facts about BIOCON <ul><li>Biocon is India's first and largest biotechnology company </li></ul><ul><li>First biotechnology company to export microbial enzymes to USA and Europe </li></ul><ul><li>First biotechnology company to receive ISO 9001 certification in India </li></ul><ul><li>The company ranks first in Asia in terms of revenues and market capitalisation and sixteenth globally. </li></ul>
  7. 8. Products of BIOCON <ul><li>Anti-Diabetic Agents </li></ul><ul><li>Anti-Hypertensive Agents </li></ul><ul><li>Anti-Inflammatory Agents </li></ul><ul><li>Antioxidants </li></ul><ul><li>Cardiovascular Agents </li></ul><ul><li>Digestive Aid Enzymes </li></ul><ul><li>Haemostatic Agents </li></ul><ul><li>Hepatoprotective Agents </li></ul><ul><li>Immunosuppressants </li></ul><ul><li>Nutraceuticals </li></ul>
  8. 9. Services of BIOCON <ul><li>Licensing </li></ul><ul><li>Contract Manufacturing </li></ul><ul><li>Research Services </li></ul>
  9. 10. Business BIOCON <ul><li>Split Business Technique (SBT) </li></ul><ul><li>Divided their business into three subunits that are collaborative with each other and at the same time they are individual in operation. </li></ul><ul><li>Syngene </li></ul><ul><li>Clinigene </li></ul><ul><li>Biocon </li></ul>
  10. 11. <ul><li>Pre-Clinical Discovery </li></ul><ul><li>Services- IPR, laboratory setups and molecular discovery. </li></ul>
  11. 12. CLINIGENE <ul><li>Clinical Development </li></ul><ul><li>Services- National level biological surveys </li></ul>
  12. 13. BIOCON <ul><li>Commercialization </li></ul><ul><li>Marketing for International health products </li></ul>
  13. 14. ADVANTAGES OF SBT <ul><li>Scope of R&D and manufacturing operations increases. </li></ul><ul><li>Facilitates new product discovery. </li></ul><ul><li>Provide multiple revenue streams to balance risk </li></ul><ul><li>Driving more innovation </li></ul><ul><li>Accelerate growth </li></ul><ul><li>Facilitate the delivery of product in the time. </li></ul>
  14. 15. Subsidiary Companies <ul><li>Syngene International Limited </li></ul><ul><li>Clinigene International Limited </li></ul><ul><li>Biocon Biopharmaceuticals Private Limited (BBPL) </li></ul><ul><li>AxiCorp –BASED IN EUROPE </li></ul><ul><li>NeoBiocon –BASED IN ABU DHABI </li></ul>
  15. 16. HRM in BIOCON <ul><li>Biocon employee approximately 3600 qualified personnel - from biologists, chemists, medical practitioners, pharmacologists, engineers, finance / legal / marketing analysts, HR generalists to general administrators. </li></ul><ul><li>15% of Biocon employees are women </li></ul><ul><li>The average age of the employees is 29 years. </li></ul>
  16. 17. Departments <ul><li>Top mangment </li></ul><ul><li>Middle level mangmnet </li></ul><ul><ul><ul><li>HRM </li></ul></ul></ul><ul><ul><ul><li>FINANCE </li></ul></ul></ul><ul><ul><ul><li>MARKETING </li></ul></ul></ul><ul><ul><ul><li>OPRATIONS </li></ul></ul></ul><ul><ul><ul><li>IT </li></ul></ul></ul><ul><li>R &D </li></ul><ul><li>QA & QC </li></ul><ul><li>Packaging </li></ul><ul><li>Regulatory Affairs </li></ul>
  17. 18. Startergic Collabration <ul><li>BIOCON - MYLAN: 2009 </li></ul><ul><li>BIOCON - ISB: 2009 </li></ul><ul><li>SYNGENE - DuPONT CROP PROTECTION: 2009 </li></ul><ul><li>SYNGENE - SAPIENT DISCOVERY 2009 </li></ul><ul><li>BIOCON-ABRAXIS: 2007 </li></ul><ul><li>BIOCON- DEAKIN UNIVERSITY: 2007 </li></ul><ul><li>SYNGENE- BRISTOL-MYERS SQUIBB: 2007 </li></ul><ul><li>BIOCON- NEOPHARMA: 2007 </li></ul>
  18. 19. Financial front <ul><li>The paid-up capital of Syngene as on March 31st, 2009 is Rs. 28,750,000. </li></ul><ul><li>The paid-up capital of Clinigene as on March 31st, 2009 is Rs. 500,000 </li></ul><ul><li>On December 31st 2008, the subscribed capital of AxiCorp is € 116,000 </li></ul><ul><li>The paid-up capital of BBPL as on March 31st, 2009 is Rs. 176,000,000 </li></ul><ul><li>The paid up capital of NeoBiocon as on March 31st, 2009 is AED 300,000 </li></ul><ul><li>SHARE PRICE - 228.95 (BSE) </li></ul>
  19. 20. Objective of the company <ul><li>To be an integrated biotechnology enterprise of global distinction. </li></ul><ul><li>If you want India to become better then the best, let the BIOCON be your guest. </li></ul>
  20. 21. THANK YOU

×